Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Thiophosphate nucleosides for the treatment of HCV

Thiophosphate nucleosides for the treatment of HCV

US Patent 9339541 · Granted May 17, 2016

Estimated economic value: $80,713,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Advantageous anti-HCV combination therapy2025
Vehicle localization system and method2025
Niraparib salts2025
Highly active compounds against COVID-192025
Crystalline epinephrine malonate salt2024
β-D-2′-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nuc2024
Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus2024
Methods and systems to enhance pipeline trajectory reconstruction using pipeline2024
2′-substituted-N6-substituted purine nucleotides for RNA virus treatment2024
Highly active compounds against COVID-192023
Highly active compounds against COVID-192023
Cyclic phosphate substituted nucleoside derivatives for the treatment of liver d2023